References

• Wang, W., Volkow, N. D., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024). Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nature Communications, 15, 4548. https://doi.org/10.1038/s41467-024-48780-6
• Hendershot, C. S., Bremmer, M. P., Paladino, M. B., Kostantinis, G., Gilmore, T. A., Sullivan, N. R., Tow, A. C., Dermody, S. S., Prince, M. A., Jordan, R., McKee, S. A., Fletcher, P. J., Claus, E. D., & Klein, K. R. (2025). Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 82(4), 395–405. https://doi.org/10.1001/jamapsychiatry.2024.4789
• Schacht, J. P., Sakai, J. T., Raymond, K., & Shelton, R. (2026). Oral semaglutide for alcohol use disorder: A randomized clinical trial. American Journal of Psychiatry. Advance online publication. https://doi.org/10.1176/appi.ajp.20260003